Psychiatric Times January 18, 2025
Mark Jankelow, MSN, PMHNP-BC

Key Takeaways

  • Atypical antipsychotics have revolutionized bipolar disorder treatment, offering options unavailable 40 years ago, significantly enhancing patient care.
  • Mark Jankelow emphasized the importance of these advancements at the Real Psychiatry conference, highlighting the progress in treatment strategies.
  • The session “One and DONE Options for Treating Bipolar Disorder” focused on applying current evidence to practice, presented by Jankelow and Michael Asbach.
  • Jankelow’s extensive experience in psychiatric care underscores the value of integrating evidence-based approaches in managing bipolar disorder.

How has bipolar treatment changed over the past 40 years? The celebration of 40 years of Psychiatric Times continues at the Real Psychiatry conference.

Mark Jankelow, MSN, PMHNP-BC, shares a little about the changes in bipolar disorder treatment over the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Provider
Related Articles:
Independent Surgeons Are Disappearing. Here's Why That Matters.
Finding your “why”: lessons for future medical students
Hormone Therapy Not Linked to Sex-Based Difference in Glioma Incidence
Opinion: Dementia risk, higher than thought, requires a national strategy
California county agrees to buy hospital in $150M deal

Share This Article